In this study, we discovered that the expression of DAPK2 is lower in patients with T1-3 tumors than in patients with T4 tumors, suggesting that the expression of DAPK2 is related to the local tumor progression and metastasis. This evidence concerns the gene DAPK2 and neoplasm.